#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	1138	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2924	90.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1871	1871	C	104	C,G	93,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	2432	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4346	133.2	0	.	n	.	0	T695C	SNP	695	695	T	1406	1406	C	121	C	119	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	2432	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4346	133.2	0	.	n	.	0	G856C	SNP	856	856	G	1567	1567	C	109	C,A	95,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	2432	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4346	133.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	2048	2048	A	125	A	115	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	2432	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4346	133.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2682	2682	C	189	C,T	176,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	2432	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4346	133.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2756	2756	A	179	A	167	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	2432	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4346	133.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	3308	3308	C	193	C,T,A	183,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_N_01367c	folP.WHO_N_01367c	1	1	539	436	folP	852	852	98.24	folP.l15.c4.ctg.1	2076	47.3	0	.	p	.	0	R7Q	NONSYN	19	21	CGG	687	689	CAG	60;61;61	C;A;G	57;59;59	.	.
folP.WHO_N_01367c	folP.WHO_N_01367c	1	1	539	436	folP	852	852	98.24	folP.l15.c4.ctg.1	2076	47.3	0	.	p	.	0	E12K	NONSYN	34	36	GAA	702	704	AAA	62;62;62	A,C;A;A,C	59,1;59;59,1	.	.
folP.WHO_N_01367c	folP.WHO_N_01367c	1	1	539	436	folP	852	852	98.24	folP.l15.c4.ctg.1	2076	47.3	0	.	p	.	0	F31L	NONSYN	91	93	TTT	759	761	TTG	64;64;64	T;T;G,T	61;54;58,1	.	.
folP.WHO_N_01367c	folP.WHO_N_01367c	1	1	539	436	folP	852	852	98.24	folP.l15.c4.ctg.1	2076	47.3	0	.	p	.	0	S68P	NONSYN	202	204	TCG	870	872	CCG	60;60;60	C;C;G	48;47;50	.	.
folP.WHO_N_01367c	folP.WHO_N_01367c	1	1	539	436	folP	852	852	98.24	folP.l15.c4.ctg.1	2076	47.3	0	.	p	.	0	F72Y	NONSYN	214	216	TTC	882	884	TAT	56;57;57	T;A,C;T	52;52,1;54	.	.
folP.WHO_N_01367c	folP.WHO_N_01367c	1	1	539	436	folP	852	852	98.24	folP.l15.c4.ctg.1	2076	47.3	0	.	p	.	0	P74S	NONSYN	220	222	CCG	888	890	TCG	53;52;52	T;C,T;G,C	49;45,1;48,1	.	.
folP.WHO_N_01367c	folP.WHO_N_01367c	1	1	539	436	folP	852	852	98.24	folP.l15.c4.ctg.1	2076	47.3	0	.	p	.	0	A89V	NONSYN	265	267	GCG	933	935	GTG	49;49;49	G;T,C,G;G	45;39,1,1;43	.	.
folP.WHO_N_01367c	folP.WHO_N_01367c	1	1	539	436	folP	852	852	98.24	folP.l15.c4.ctg.1	2076	47.3	0	.	p	.	0	E151K	NONSYN	451	453	GAA	1119	1121	AAA	76;79;79	A,C;A;A	64,3;70;71	.	.
folP.WHO_N_01367c	folP.WHO_N_01367c	1	1	539	436	folP	852	852	98.24	folP.l15.c4.ctg.1	2076	47.3	1	SNP	p	R228S	1	.	.	682	684	AGC	1350	1352	AGC	61;60;61	A;G;C	57;57;56	folP.WHO_N_01367c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	155	878	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3987	52.0	1	SNP	p	S91F	0	.	.	271	273	TCC	937	939	TCC	34;34;33	T;C;C	28;30;31	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	155	878	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3987	52.0	1	SNP	p	D95N	0	.	.	283	285	GAC	949	951	GAC	35;34;36	G,T;A;C,T	32,1;31;32,1	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	155	878	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3987	52.0	1	SNP	p	D95G	0	.	.	283	285	GAC	949	951	GAC	35;34;36	G,T;A;C,T	32,1;31;32,1	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	155	878	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3987	52.0	0	HET	.	.	.	T551C,G	.	551	551	T	1217	1217	T	55	T,C,G	31,6,4	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	155	878	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3987	52.0	0	HET	.	.	.	C2313G,T	.	2313	2313	C	2979	2979	C	58	C,G,T	31,5,1	.	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	316	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	2084	36.2	1	SNP	p	G45D	1	.	.	133	135	GAC	843	845	GAC	86;86;86	G;A;C	79;77;78	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	248	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1600	36.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	1048	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3588	68.8	1	SNP	p	D86N	0	.	.	256	258	GAC	887	889	GAC	58;56;58	G;A,T;C	41;32,1;42	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	1048	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3588	68.8	1	SNP	p	S88P	0	.	.	262	264	TCC	893	895	TCC	62;61;59	T;C,T;C	57;51,3;53	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	902	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3548	60.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	2016	2018	GGC	68;68;68	G;G;C	51;50;49	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.15.002	penA.15.002	1	1	27	586	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2362	55.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1346	1348	GCA	84;85;85	G;C;A,T,C	76;74;75,1,1	penA.15.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.002	penA.15.002	1	1	27	586	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2362	55.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1349	1351	ATC	86;86;86	A;T,A;C,T	75;80,1;80,1	penA.15.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.002	penA.15.002	1	1	27	586	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2362	55.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1361	1363	GTG	81;81;81	G,C;T,G,C;G	72,1;71,1,1;73	penA.15.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.002	penA.15.002	1	1	27	586	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2362	55.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1361	1363	GTG	81;81;81	G,C;T,G,C;G	72,1;71,1,1;73	penA.15.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.002	penA.15.002	1	1	27	586	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2362	55.8	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1862	1864	ACC	48;48;45	A;C;C,G	32;38;39,1	penA.15.002:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.002	penA.15.002	1	1	27	586	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2362	55.8	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1916	1918	GCG	35;35;35	G;C;G,C	27;25;24,1	penA.15.002:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.002	penA.15.002	1	1	27	586	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2362	55.8	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1916	1918	GCG	35;35;35	G;C;G,C	27;25;24,1	penA.15.002:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.002	penA.15.002	1	1	27	586	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2362	55.8	1	SNP	p	G542S	0	.	.	1624	1626	GGC	2039	2041	GGC	46;46;46	G;G,T;C,T	43;42,1;42,1	penA.15.002:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.002	penA.15.002	1	1	27	586	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2362	55.8	1	SNP	p	G545S	0	.	.	1633	1635	GGC	2048	2050	GGC	42;43;43	G;G;C	39;35;31	penA.15.002:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.002	penA.15.002	1	1	27	586	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2362	55.8	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2066	2068	CCG	46;45;44	C;C;G,C	35;37;37,2	penA.15.002:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	760	ponA	2397	2397	99.96	ponA.l6.c30.ctg.1	4126	42.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	2428	2430	CCG	64;64;64	C,G,T;C,G,T;G,C,T	40,3,1;49,1,1;41,2,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	252	porA	1146	1146	99.83	porA.l15.c30.ctg.1	1877	29.2	0	.	p	.	0	S22G	NONSYN	64	66	AGC	218	220	GGC	29;29;29	G;G;C	25;25;25	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	252	porA	1146	1146	99.83	porA.l15.c30.ctg.1	1877	29.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	400	400	C	13	C,G	9,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	290	porB1b	1035	1035	97.6	porB1b.l6.c4.ctg.1	2404	28.6	0	.	p	.	0	.	INDELS	629	630	AA	1334	1336	TAG	29;29;31	T,A;A;G	25,1;26;27	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	290	porB1b	1035	1035	97.6	porB1b.l6.c4.ctg.1	2404	28.6	0	.	p	.	0	.	MULTIPLE	631	633	TAC	1338	1341	CAAT	31;32;35;35	C;A,T;A;T	28;28,1;32;32	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	290	porB1b	1035	1035	97.6	porB1b.l6.c4.ctg.1	2404	28.6	0	.	p	.	0	N212fs	FSHIFT	634	634	A	1343	1343	T	35	T,A	31,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	290	porB1b	1035	1035	97.6	porB1b.l6.c4.ctg.1	2404	28.6	1	SNP	p	G120K	0	.	.	358	360	GGT	1062	1064	GGT	31;31;32	G;G;T,G	29;28;26,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	290	porB1b	1035	1035	97.6	porB1b.l6.c4.ctg.1	2404	28.6	1	SNP	p	A121D	0	.	.	361	363	GCC	1065	1067	GCC	32;32;32	G,T;C;C	26,1;28;27	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	290	porB1b	1035	1035	97.6	porB1b.l6.c4.ctg.1	2404	28.6	1	SNP	p	A121N	0	.	.	361	363	GCC	1065	1067	GCC	32;32;32	G,T;C;C	26,1;28;27	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	620	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5231	28.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	36	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1046	7.7	1	SNP	p	V57M	1	.	.	169	171	ATG	499	501	ATG	7;7;7	A;T;G	7;7;7	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
